<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>DISEASE CHARACTERISTICS:   Collagen type VI-related disorders include Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> and Ullrich <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (CMD) </plain></SENT>
<SENT sid="1" pm="."><plain>Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> is characterized by the combination of <z:hpo ids='HP_0003701'>proximal muscle weakness</z:hpo> and variable <z:hpo ids='HP_0001371'>contractures</z:hpo>, affecting most frequently the long finger flexors, elbows, and ankles </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0003674'>onset</z:hpo> of Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> may be prenatal (characterized by <z:hpo ids='HP_0001558'>decreased fetal movements</z:hpo>), neonatal (<z:mp ids='MP_0004144'>hypotonia</z:mp> or torticollis), in early childhood (<z:hpo ids='HP_0001270'>delayed motor milestones</z:hpo>, <z:hpo ids='HP_0001324'>muscle weakness</z:hpo>, and <z:hpo ids='HP_0001371'>contractures</z:hpo>), or in adulthood (proximal <z:mp ids='MP_0000746'>weakness</z:mp> and Achilles tendon or long finger flexor <z:hpo ids='HP_0001371'>contractures</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>Because of slow but ongoing progression, more than two-thirds of affected individuals over age 50 years rely on supportive means for outdoor mobility </plain></SENT>
<SENT sid="4" pm="."><plain>Respiratory involvement is rare and seems to be related to more severe <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> in later life </plain></SENT>
<SENT sid="5" pm="."><plain>Ullrich CMD is characterized by congenital <z:mp ids='MP_0000746'>weakness</z:mp> and <z:mp ids='MP_0004144'>hypotonia</z:mp>, proximal <z:hpo ids='HP_0001371'>joint contractures</z:hpo>, and striking hyperlaxity of distal joints </plain></SENT>
<SENT sid="6" pm="."><plain>Some affected children acquire the ability to walk independently; however, progression of the disease often results in later loss of ambulation </plain></SENT>
<SENT sid="7" pm="."><plain>Early and severe respiratory involvement may require artificial ventilatory support in the first or second decade of life </plain></SENT>
<SENT sid="8" pm="."><plain>Although originally described as separate entities, Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> and Ullrich CMD represent a clinical continuum in which individuals presenting with intermediate phenotypes could be considered to have either "mild Ullrich CMD" or "severe Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo>." DIAGNOSIS/TESTING:   Diagnosis depends on typical clinical features, with the serum <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase concentration usually being <z:mpath ids='MPATH_458'>normal</z:mpath> or only mildly elevated and muscle biopsy showing myopathic or dystrophic changes </plain></SENT>
<SENT sid="9" pm="."><plain>In Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo>, collagen VI immunolabeling of muscle is usually <z:mpath ids='MPATH_458'>normal</z:mpath> or shows subtle alterations only </plain></SENT>
<SENT sid="10" pm="."><plain>In Ullrich CMD, collagen VI immunolabeling is absent or markedly reduced from the endomysium and basal lamina, but may be <z:mpath ids='MPATH_458'>normal</z:mpath> around capillaries </plain></SENT>
<SENT sid="11" pm="."><plain>Mutations in the genes COL6A1, COL6A2, and COL6A3 are associated with Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> and Ullrich CMD </plain></SENT>
<SENT sid="12" pm="."><plain>Molecular genetic testing is available on a clinical basis </plain></SENT>
<SENT sid="13" pm="."><plain>MANAGEMENT:  Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo>/Ullrich CMD: Physiotherapy advice regarding stretching, splinting, and mobility <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">aids</z:e>; possible orthopedic assessment if surgery for <z:hpo ids='HP_0001771'>Achilles tendon contractures</z:hpo> is to be considered; respiratory surveillance for possible <z:hpo ids='HP_0002877'>nocturnal hypoventilation</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>Prophylaxis of <z:e sem="disease" ids="C0149725" disease_type="Disease or Syndrome" abbrv="LRTI">chest infections</z:e> with vaccination and physiotherapy; aggressive treatment of <z:hpo ids='HP_0006532'>pulmonary infections</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain>In addition for Ullrich CMD: Assessment of nutritional status and growth; management of <z:hpo ids='HP_0011968'>feeding difficulties</z:hpo> </plain></SENT>
<SENT sid="16" pm="."><plain>Active surveillance for development of <z:hpo ids='HP_0002650'>scoliosis</z:hpo>; therapy for <z:hpo ids='HP_0002650'>scoliosis</z:hpo> as indicated </plain></SENT>
<SENT sid="17" pm="."><plain>GENETIC COUNSELING:   Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> is inherited in an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> manner and Ullrich CMD classically in an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> manner although dominant <z:hpo ids='HP_0000005'>inheritance</z:hpo> secondary to de novo mutations can occur </plain></SENT>
<SENT sid="18" pm="."><plain>Individuals with Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> are heterozygous for a COL6A1, COL6A2, or COL6A3 mutation and are symptomatic </plain></SENT>
<SENT sid="19" pm="."><plain>They may have an affected parent </plain></SENT>
<SENT sid="20" pm="."><plain>Parents of individuals with <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> Ullrich CMD are usually heterozygous for a COL6A1, COL6A2, or COL6A3 mutation, but do not appear to manifest related symptoms </plain></SENT>
<SENT sid="21" pm="."><plain>Each child of an individual with Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> has a 50% chance of inheriting the condition; no individuals with Ullrich CMD have been known to reproduce </plain></SENT>
<SENT sid="22" pm="."><plain>The risk to the sibs of the proband depends upon the genetic status of the proband's parents.   For parents of a proband with proven <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> Ullrich CMD: at conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being neither affected nor a carrier </plain></SENT>
<SENT sid="23" pm="."><plain>No laboratories offering direct molecular genetic testing for prenatal diagnosis for Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> or Ullrich CMD are listed in the GeneTests Laboratory Directory </plain></SENT>
<SENT sid="24" pm="."><plain>However, prenatal testing may be available for families in which the disease-causing mutation has been identified in an affected family member </plain></SENT>
</text></document>